Biotricity Achieves Cashflow Breakeven with Record Revenue Growth

Redwood City, Monday, 17 February 2025.
Biotricity’s Q3-FY25 sees a 22% revenue increase to $3.6 million, achieving cashflow breakeven. This marks a major financial milestone, showcasing its strategic advancement in medical technology.